Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-09

Clinical Trial Update: Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating dapagliflozin in adolescents and adults with Type 1 diabetes was terminated. The study also included subjects with diabetic ketoacido…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Kinderkrankenhaus auf der Bult | Conditions: Type 1 Diabetes, Diabetic Ketoacidosis | Phase 1 | Status: TERMINATED